Home › NDC Lookup › RxCUI directory › RxCUI 2633021

Leniolisib 70 MG Oral Tablet [Joenja] — RxCUI 2633021

RxNorm drug concept · Semantic branded drug
RxCUI 2633021 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2633021
Official nameLeniolisib 70 MG Oral Tablet [Joenja]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asJoenja 70 MG Oral Tablet; Joenja 70 MG (equivalent to leniolisib phosphate 85.26 MG) Oral Tablet
FDA products mapped1
Package NDCs mapped1
Reported Medicaid activity (SDUD)114 prescriptions · 3 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Leniolisib: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • APDS is a rare inherited immune disorder caused by a gene change that makes a specific enzyme — called PI3K-delta — work in overdrive. That throws your immune cells out of balance...
  • What exactly is APDS, and how does Joenja help?
  • Timing does matter in the sense that you should take your two daily doses about 12 hours apart — for example, morning and evening — to keep steady levels in your body. The good new...
  • Does it matter what time of day I take Joenja, or whether I eat first?
📖 Read our full Leniolisib guide →

🕸️ Concept Web — How Leniolisib 70 MG Oral Tablet [Joenja] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Leniolisib 70 MG Oral Tablet [Joenja] RxCUI 2633021

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Leniolisib 2633005
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Joenja 2633016
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Leniolisib Oral Tablet 2633014
    • Leniolisib Oral Product 2633012
    • Leniolisib Pill 2633013
    • Leniolisib Oral Tablet [Joenja] 2633020
    • Joenja Oral Product 2633018
    • Joenja Pill 2633019
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Leniolisib 70 MG Oral Tablet SCD · 2633015
  • Leniolisib 70 MG SCDC · 2633011
  • Leniolisib Oral Tablet SCDF · 2633014
  • Leniolisib Oral Product SCDG · 2633012
  • Leniolisib Pill SCDG · 2633013

Brand-Name Concepts

  • Leniolisib 70 MG [Joenja] SBDC · 2633017
  • Leniolisib Oral Tablet [Joenja] SBDF · 2633020
  • Joenja Oral Product SBDG · 2633018
  • Joenja Pill SBDG · 2633019
  • Joenja BN · 2633016

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2633021 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
71274-0170-60 1 BOTTLE, PLASTIC in 1 CARTON (71274-170-60) / 60 TABLET, F... Joenja Pharming Healthcare Inc. 2023-03-29
Observed labelers: Pharming Healthcare Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.